Faculty slides approved for release are now available.
Are We Ready to Move Beyond Standard Imaging for Surveillance? MTV and Radiomics – Maryellen Giger, PhD
Are We Ready to Move Beyond Standard Imaging for Surveillance? ctDNA – Mark Roschewski, MD
“Dual” Keynote Symposium: A Look at the Advancement of Lymphoma Therapy Over the Last 20 Years
“Dual” Keynote Symposium: Experts Debate the Role of Transplant in PTCL
DEBATE: CAR T-cell Therapy Should be Standard Therapy For All Patients with Early Relapsed DLBCL
Time (CST)
Friday, April 21
1:00 PM – 1:05 PM
Welcome and Introductions
1:05 PM – 2:30 PM
1:05 – 1:10 PM Pre-session ARS
1:10 – 1:30 PM: From Cell of Origin to Mutational Landscape
David Scott, MBChB PhD
1:30 – 1:50 PM: Molecular Monitoring of Lymphoma with ctDNA
1:50 – 2:10 PM: Immune Microenvironment of Lymphoma
Stephen Ansell, MD, PhD
2:30 PM – 2:50 PM
Break & Exhibits
2:50PM – 5:00 PM
Mini Symposium on Classification and Imaging in Lymphoma
2:50 – 3:50 PM: Keynote: Evolution in the Classification of Lymphoma: From WHO to ICC – Where do we go from here?
3:50 – 4:30 PM: PET Imaging in Lymphoma
4:30 – 4:50 PM: How Many Scans are Too Many?
Carrie Thompson, MD, MS
4:50 – 5:10 PM: Panel discussion, Q&A, and Post-session ARS
5:10 PM
General Session Wrap Up and Summary
Time (CST)
Saturday, April 22
8:00 AM – 8:05 AM
Welcome and Introductions
8:00 AM – 8:25 AM
Practical Strategies for Diversity, Equity, and Inclusion in Clinical Lymphoma Research
Ruemu Birhiray, MD
8:25 AM – 9:50 AM
Mini Symposium on Hodgkin Lymphoma
8:25 – 8:30 AM: Pre-session ARS
8:35 – 8:55 AM: Frontline Approaches for Previously Untreated HL
Jonathan Friedberg, MD, MMSc
8:55 – 9:15 AM: Treating Relapsed/Refractory HL
Ann LaCasce, MD, MMSc
9:15 – 9:35 AM: Caring for Older/Comorbid Patients with HL
Andrew Evens, DO, MBA, MSc
9:35 – 9:50 AM: Panel discussion with speakers, Q&A, and post-session ARS
9:50 AM – 10:10 AM
Break & Virtual Exhibit
10:10 AM – 12:00 PM
20 Years of IUCLS
10:10 – 10:15 AM: Pre-session ARS
10:15 – 10:35 AM: A Look Back at 20 Years of IUCLS
10:35 – 11:15 AM: “Dual” Keynote Symposium: A Look at the Advancement of Lymphoma Therapy Over the Last 20 Years
11:15 – 11:55 AM: “Duel” Keynote Symposium: Experts Debate the Role of Transplant in PTCL
11:55 AM – 12:00 PM: Panel discussion, Q&A, and Post-session ARS
12:00 PM – 1:00 PM
Lunch & Exhibits
1:00 PM – 2:25 PM
Mini Symposium on Transplant and Cellular Therapy
1:00 – 1:05 PM: Pre-session ARS
1:05 – 1:25 PM: Where do Auto and Allo SCT Have a Role in Lymphoid Malignancies?
1:25 – 1:45 PM: Sequencing of CAR T-cell Therapy
1:45 – 2:05 PM: Resistance to Cellular Therapy
Catherine Bollard, MD, MBChB
2:05 – 2:25 PM: Panel discussion with speakers, Q&A, and post-session ARS
2:25 PM – 2:45 PM
Break & Virtual Exhibits
2:45 PM – 4:10 PM
Mini Symposium on Follicular Lymphoma
2:45 – 2:50 PM: Pre-session ARS
2:50 – 3:10 PM: Historical Perspectives of FL
Leo Gordon, MD
3:10 –3:30 PM: Future Directions in the Treatment of FL
Brad Kahl, MD
3:30 – 3:50 PM: Current Gaps of Treatment
Loretta Nastoupil, MD
3:50 – 4:10 PM: Panel discussion, Q&A, and Post-session ARS
4:10 – 4:30PM
Summary and Best of IUCLS
4:30 PM
Adjourn